Cargando…
Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726015/ https://www.ncbi.nlm.nih.gov/pubmed/33324192 http://dx.doi.org/10.3389/fnagi.2020.00232 |
| _version_ | 1783620801884323840 |
|---|---|
| author | Belbin, Olivia Lehmann, Sylvain Sabidó, Eduard Hirtz, Christophe |
| author_facet | Belbin, Olivia Lehmann, Sylvain Sabidó, Eduard Hirtz, Christophe |
| author_sort | Belbin, Olivia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7726015 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77260152020-12-14 Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases Belbin, Olivia Lehmann, Sylvain Sabidó, Eduard Hirtz, Christophe Front Aging Neurosci Neuroscience Frontiers Media S.A. 2020-11-26 /pmc/articles/PMC7726015/ /pubmed/33324192 http://dx.doi.org/10.3389/fnagi.2020.00232 Text en Copyright © 2020 Belbin, Lehmann, Sabidó and Hirtz. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Neuroscience Belbin, Olivia Lehmann, Sylvain Sabidó, Eduard Hirtz, Christophe Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases |
| title | Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases |
| title_full | Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases |
| title_fullStr | Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases |
| title_full_unstemmed | Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases |
| title_short | Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases |
| title_sort | editorial: proteomics as a tool for biomarker and drug target discovery: improving the diagnosis and treatment of neurodegenerative diseases |
| topic | Neuroscience |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726015/ https://www.ncbi.nlm.nih.gov/pubmed/33324192 http://dx.doi.org/10.3389/fnagi.2020.00232 |
| work_keys_str_mv | AT belbinolivia editorialproteomicsasatoolforbiomarkeranddrugtargetdiscoveryimprovingthediagnosisandtreatmentofneurodegenerativediseases AT lehmannsylvain editorialproteomicsasatoolforbiomarkeranddrugtargetdiscoveryimprovingthediagnosisandtreatmentofneurodegenerativediseases AT sabidoeduard editorialproteomicsasatoolforbiomarkeranddrugtargetdiscoveryimprovingthediagnosisandtreatmentofneurodegenerativediseases AT hirtzchristophe editorialproteomicsasatoolforbiomarkeranddrugtargetdiscoveryimprovingthediagnosisandtreatmentofneurodegenerativediseases |